Home > Human Primary Cells > Carcinoma Associated Fibroblasts >

Primary Human Breast Cancer Associated Fibroblasts - PCD-10-0110

Growth of primary cells at day 1 and day 7, X40.
 
US Price: $1,250.00

Description Sterility and Pathogen Testing
 
Primary Human Triple Negative Breast Cancer Associated Fibroblasts
Donor ID# 511616A1
Lot # DT01252P1
~0.5 Million Viable Cells/Vial
Post Thaw Viability >80%
Growth Medium: DMEM with 10% FBS (HI)
Cryo Date: 6-Jan, 2017

Soc Hx
Gender: Female
Age: 61
Race: White
Height: 160cm
Weight: 74kg
BMI: 28.9
Smoker: Previous Use, 40 smoke(s)/day, 45 years
Alcohol: Current Use, 2.5 drink(s)/day
Clinical Information
Clinical Dx: Metaplastic carcinoma of the breast, Myocardial infarction, Congestive heart failure, Hypercholesterolemia, Defibrillator placement, Irregular heartbeat, Chronic obstructive pulmonary disease, Hypothyroidism, Arthritis, Depression,
Tumor Staging: IIa
Status ER- / PR- / HER2 0
Additional IHC: Vimentin >95%, Co-expression of pan-cytokeratin 80-90%
Medication: Theophylline, Omeprazole, Nicotine patch, Ipratropium and albuterol, Lasix, Fluticasone and vilanterol, Fluticasone and salmeterol, Fluticasone propionate, Aspirin and calcium carbonate, Xanax
Pathology of Donor Material: Carcinoma